Valiant Laboratories Limited (VALIANTLAB.NS)
INR 93.79
(0.34%)
INR 93.79
(0.34%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 649.9 Million INR | 10.24% |
| 2022 | 589.55 Million INR | -3.34% |
| 2021 | 609.95 Million INR | 1930.03% |
| 2020 | -33.33 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.43 Billion INR | 121.3% |
| 2023 Q4 | 649.9 Million INR | 237.87% |
| 2023 FY | 649.9 Million INR | 10.24% |
| 2023 Q2 | 607.08 Million INR | 7.97% |
| 2023 Q1 | 562.26 Million INR | -4.63% |
| 2023 Q3 | 192.35 Million INR | -68.32% |
| 2022 Q4 | 589.55 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | 83.189% |
| Hester Biosciences Limited | 2.29 Billion INR | 71.629% |
| Aarti Drugs Limited | 5.54 Billion INR | 88.287% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | 75.118% |
| Albert David Limited | -278.36 Million INR | 333.468% |
| Alembic Limited | 66.9 Million INR | -871.453% |
| Alkem Laboratories Limited | -1.6 Billion INR | 140.382% |
| Bafna Pharmaceuticals Limited | 229.93 Million INR | -182.648% |
| Bajaj HealthCare Limited | 3.29 Billion INR | 80.3% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 3623.268% |
| Brooks Laboratories Limited | 49.48 Million INR | -1213.331% |
| Eris Lifesciences Limited | 13.8 Billion INR | 95.293% |
| FDC Limited | -57.75 Million INR | 1225.332% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 122.862% |
| Gufic Biosciences Limited | 3.19 Billion INR | 79.654% |
| Hikal Limited | 7.96 Billion INR | 91.843% |
| Ind-Swift Limited | 9.5 Billion INR | 93.165% |
| Innova Captab Limited | 2.33 Billion INR | 72.152% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 159.012% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 146.758% |
| Jubilant Pharmova Limited | 27.07 Billion INR | 97.599% |
| Lincoln Pharmaceuticals Limited | -127.63 Million INR | 609.176% |
| Lupin Limited | 19.38 Billion INR | 96.647% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | 33.399% |
| Medico Remedies Limited | 78.67 Million INR | -726.038% |
| Morepen Laboratories Limited | -231.17 Million INR | 381.131% |
| Nectar Lifesciences Limited | 6.15 Billion INR | 89.445% |
| Orchid Pharma Limited | -1.31 Billion INR | 149.466% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 127.679% |
| RPG Life Sciences Limited | -364.7 Million INR | 278.202% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | -441.409% |
| Sigachi Industries Limited | 859.94 Million INR | 24.426% |
| Solara Active Pharma Sciences Limited | 10.03 Billion INR | 93.522% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | -348.282% |
| Themis Medicare Limited | 764.96 Million INR | 15.041% |
| Unichem Laboratories Limited | 931.91 Million INR | 30.262% |
| Vaishali Pharma Limited | 119.13 Million INR | -445.517% |
| Wanbury Limited | 1.1 Billion INR | 41.232% |
| Windlas Biotech Limited | -273.04 Million INR | 338.024% |
| ZIM Laboratories Limited | 983.6 Million INR | 33.926% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 115.649% |
| Ipca Laboratories Limited | 11.41 Billion INR | 94.307% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 100.897% |
| Venus Remedies Limited | -267.7 Million INR | 342.773% |
| Sakar Healthcare Limited | 790.93 Million INR | 17.831% |
| Aurobindo Pharma Limited | 3.69 Billion INR | 82.403% |
| Divi's Laboratories Limited | -39.77 Billion INR | 101.634% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 112.966% |
| Mankind Pharma Limited | -1.74 Billion INR | 137.172% |
| Sequent Scientific Limited | 4.17 Billion INR | 84.447% |
| Laurus Labs Limited | 24.35 Billion INR | 97.332% |
| Neuland Laboratories Limited | -214.05 Million INR | 403.61% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | 76.964% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 115.166% |
| Zydus Lifesciences Limited | 3.91 Billion INR | 83.387% |
| Amrutanjan Health Care Limited | -248.79 Million INR | 361.223% |
| Wockhardt Limited | 18.27 Billion INR | 96.443% |
| Bal Pharma Limited | 1.26 Billion INR | 48.566% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 94.967% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 156.135% |
| Par Drugs and Chemicals Limited | -366.53 Million INR | 277.308% |
| Caplin Point Laboratories Limited | -5.5 Billion INR | 111.8% |
| Shilpa Medicare Limited | 9.06 Billion INR | 92.834% |
| Ajanta Pharma Limited | -954.9 Million INR | 168.06% |
| Aarey Drugs & Pharmaceuticals Limited | 297.57 Million INR | -118.396% |
| Granules India Limited | 9.28 Billion INR | 93.002% |
| Medicamen Biotech Limited | 160.31 Million INR | -305.388% |
| Syncom Formulations (India) Limited | 46.21 Million INR | -1306.379% |
| Piramal Enterprises Limited | 491.39 Billion INR | 99.868% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 97.958% |
| NATCO Pharma Limited | -5.81 Billion INR | 111.172% |
| Suven Life Sciences Limited | -1.63 Billion INR | 139.805% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 66.377% |
| Strides Pharma Science Limited | 23.25 Billion INR | 97.206% |
| Indoco Remedies Limited | 6.47 Billion INR | 89.965% |
| Alpa Laboratories Limited | 35.36 Million INR | -1737.802% |
| Lasa Supergenerics Limited | 205.79 Million INR | -215.795% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 169.006% |